Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Fisher & Paykel Healthcare Corporation Ltd banner

Fisher & Paykel Healthcare Corporation Ltd
F:FPLB

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
Watchlist
Price: 21.8 EUR 1.87% Market Closed
Market Cap: €12.7B
Write Note Create Alert Ask AI

Wall St Price Targets

FPLB Price Targets Summary
Fisher & Paykel Healthcare Corporation Ltd

Wall Street analysts forecast FPLB stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FPLB is 19.13 EUR with a low forecast of 15.88 EUR and a high forecast of 21.59 EUR.

FPLB Lowest Forecast
Wall Street Target
€15.88
-27% Downside
FPLB Average Forecast
Wall Street Target
€19.13
-12% Downside
FPLB Highest Forecast
Wall Street Target
€21.59
-1% Downside
Lowest Forecast
Price Target
15.88 EUR
27% Downside
Average Forecast
Price Target
19.13 EUR
12% Downside
Highest Forecast
Price Target
21.59 EUR
1% Downside
Fisher & Paykel Healthcare Corporation Ltd Competitors:
Price Targets

Revenue
Forecast

11% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 12%.

What are analyst estimates?

Gross Profit
Forecast

13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 4 years is 13%.

What are analyst estimates?

Operating Income
Forecast

15% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
15% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 14 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 4 years is 16%.

What are analyst estimates?

Pre-Tax Income
Forecast

15% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
15% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 18%.

What are analyst estimates?

Net Income
Forecast

15% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
15% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 4 years is 17%.

What are analyst estimates?

Continue FPLB Research

Summary
FPLB intrinsic value, competitors valuation, and company profile.
DCF Valuation
FPLB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FPLB stock valuation using valuation multiples.
Wall St Estimates
FPLB price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FPLB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Fisher & Paykel Healthcare Corporation Ltd listings:
OTC • USD
FSPKF
 ASX • AUD
FPH
 NZX • NZD
FPH
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FPLB's stock price target?
Price Target
19.13 EUR

According to Wall Street analysts, the average 1-year price target for FPLB is 19.13 EUR with a low forecast of 15.88 EUR and a high forecast of 21.59 EUR.

What is the Revenue forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
12%

Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 12%.

What is the Gross Profit forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
13%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 4 years is 13%.

What is the Operating Income forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
16%

Over the last 14 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 4 years is 16%.

What is the Pre-Tax Income forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
18%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 18%.

What is the Net Income forecast for Fisher & Paykel Healthcare Corporation Ltd?
Projected CAGR
17%

Over the last 14 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 4 years is 17%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.